4.8 Article

Large-scale characterization of peptide-MHC binding landscapes with structural simulations

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1018165108

关键词

-

资金

  1. Center new development funding
  2. Searle Scholars Fellowship

向作者/读者索取更多资源

Class I major histocompatibility complex proteins play a critical role in the adaptive immune system by binding to peptides derived from cytosolic proteins and presenting them on the cell surface for surveillance by T cells. The varied peptide binding specificity of these highly polymorphic molecules has important consequences for vaccine design, transplantation, autoimmunity, and cancer development. Here, we describe a molecular modeling study of MHC-peptide interactions that integrates sampling techniques from protein-protein docking, loop modeling, de novo structure prediction, and protein design in order to construct atomically detailed peptide binding landscapes for a diverse set of MHC proteins. Specificity profiles derived from these landscapes recover key features of experimental binding profiles and can be used to predict peptide binding with reasonable accuracy. Family wide comparison of the predicted binding landscapes recapitulates previously reported patterns of specificity divergence and peptide-repertoire diversity while providing a structural basis for observed specificity patterns. The size and sequence diversity of these structure-based binding landscapes enable us to identify subtle patterns of covariation between peptide sequence positions; analysis of the associated structural models suggests physical interactions that may mediate these sequence correlations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to β-lactam Antibiotics

Keira A. Cohen, Tal El-Hay, Kelly L. Wyres, Omer Weissbrod, Vanisha Munsamy, Chen Yanover, Ranit Aharonov, Oded Shaham, Thomas C. Conway, Yaara Goldschmidt, William R. Bishai, Alexander S. Pym

EBIOMEDICINE (2016)

Article Biochemical Research Methods

Redundancy-weighting for better inference of protein structural features

Chen Yanover, Natalia Vanetik, Michael Levitt, Rachel Kolodny, Chen Keasar

BIOINFORMATICS (2014)

Article Hematology

The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics

Zuben E. Sauna, Jay N. Lozier, Carol K. Kasper, Chen Yanover, Timothy Nichols, Tom E. Howard

Article Hematology

Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B

S. Saini, N. Hamasaki-Katagiri, G. S. Pandey, C. Yanover, C. Guelcher, V. L. Simhadri, S. Dandekar, M. F. Guerrera, C. Kimchi-Sarfaty, Z. E. Sauna

HAEMOPHILIA (2015)

Editorial Material Statistics & Probability

Comment: Causal Inference Competitions: Where Should We Aim?

Ehud Karavani, Tal El-Hay, Yishai Shimoni, Chen Yanover

STATISTICAL SCIENCE (2019)

Article Pharmacology & Pharmacy

Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson's Disease

Daphna Laifenfeld, Chen Yanover, Michal Ozery-Flato, Oded Shaham, Michal Rosen-Zvi, Nirit Lev, Yaara Goldschmidt, Iris Grossman

Summary: Research utilizing real-world healthcare data has identified two drugs with significant beneficial effects on Parkinson's disease progression, providing insights into potential disease-modifying therapeutic solutions.

FRONTIERS IN PHARMACOLOGY (2021)

Review Pediatrics

Personalized approach to childhood obesity: Lessons from gut microbiota and omics studies. Narrative review and insights from the 29th European childhood obesity congress

Aneta Gawlik, Anne Salonen, Ching Jian, Chen Yanover, Aleksandra Antosz, Michael Shmoish, Malgorzata Wasniewska, Abdullah Bereket, Stefan A. Wudy, Michaela F. Hartmann, David Thivel, Pawel Matusik, Daniel Weghuber, Ze'ev Hochberg

Summary: The traditional approach to childhood obesity prevention and treatment may not be effective for all patients due to individual variations or misclassifications, highlighting the importance of personalized medicine. High-throughput technologies like next-generation sequencing and metabolomics are valuable tools for providing precise diagnoses and developing personalized treatment approaches. This article also discusses the potential of utilizing omics data to monitor the evolution of symptoms, treatment efficacy, and predisposition to side effects in children with obesity.

PEDIATRIC OBESITY (2021)

Article Pharmacology & Pharmacy

ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-Offs

Grammati Sarri, Dimitri Bennett, Thomas Debray, Anouk Deruaz-Luyet, Montse Soriano Gabarro, Joan A. Largent, Xiaojuan Li, Wei Liu, Jennifer L. Lund, Daniela C. Moga, Mugdha Gokhale, Christopher T. Rentsch, Xuerong Wen, Chen Yanover, Yizhou Ye, Huifeng Yun, Andrew R. Zullo, Kueiyu Joshua Lin

Summary: As the fight against the COVID-19 pandemic continues, there is a growing need for comparative effectiveness research (CER) on preventive and therapeutic interventions. The use of electronic health records (EHRs) provides an opportunity to generate real-world evidence, but there are challenges in ensuring unbiased results. High-quality healthcare databases, rigorous study designs, and proper statistical methods are essential for reliable research.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Multidisciplinary Sciences

Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19

Barak Mizrahi, Maytal Bivas-Benita, Nir Kalkstein, Pinchas Akiva, Chen Yanover, Yoav Yehezkelli, Yoav Kessler, Sharon Hermoni Alon, Eitan Rubin, Gabriel Chodick

Summary: Conducting a second PCR test may help identify patients at risk for severe COVID-19, with early negative results indicating lower risk. This approach is applicable not only to recovering patients but also to those who still have evidence of COVID-19.

SCIENTIFIC REPORTS (2021)

Review Public, Environmental & Occupational Health

Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature

Richard Wyss, Chen Yanover, Tal El-Hay, Dimitri Bennett, Robert W. Platt, Andrew R. Zullo, Grammati Sari, Xuerong Wen, Yizhou Ye, Hongbo Yuan, Mugdha Gokhale, Elisabetta Patorno, Kueiyu Joshua Lin

Summary: This paper surveys current approaches and recent advancements for high-dimensional proxy confounder adjustment in healthcare database studies, focusing on feature generation, covariate prioritization, selection, and adjustment, as well as diagnostic assessment. While there is a large literature on methods for high-dimensional confounder prioritization/selection, there is relatively little written on best practices for feature generation and diagnostic assessment, indicating particular limitations and challenges in these areas. Machine-learning algorithms are showing promise in supplementing investigator-specified variables to improve confounding control in pharmacoepidemiologic studies, but further research is needed on best practices for feature generation and diagnostic assessment in this context.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Article Health Care Sciences & Services

Framework for identifying drug repurposing candidates from observational healthcare data

Michal Ozery-Flato, Yaara Goldschmidt, Oded Shaham, Sivan Ravid, Chen Yanover

JAMIA OPEN (2020)

Meeting Abstract Public, Environmental & Occupational Health

A Semantic-based visualization of drug safety profiles

Chen Yanover, Karni Marcus, Pini Akiva

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

Article Public, Environmental & Occupational Health

What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization

Chen Yanover, Barak Mizrahi, Nir Kalkstein, Karni Marcus, Pinchas Akiva, Yael Barer, Varda Shalev, Gabriel Chodick

JMIR PUBLIC HEALTH AND SURVEILLANCE (2020)

Article Health Care Sciences & Services

Inferring new relations between medical entities using literature curated term co-occurrences

Adam Spiro, Jonatan Fernandez Garcia, Chen Yanover

JAMIA OPEN (2019)

Article Endocrinology & Metabolism

Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study

Assaf Gottlieb, Chen Yanover, Amos Cahan, Yaara Goldschmidt

BMJ OPEN DIABETES RESEARCH & CARE (2017)

暂无数据